Inactive Instrument

Laboratorios Andromaco S.A. Share Price

Stocks

Personal Products

End-of-day quote Santiago S.E.
- CLP - Intraday chart for Laboratorios Andromaco S.A.
Manager TitleAgeSince
Chief Executive Officer - 15/01/2014
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%-0.38%-0.33%-6.15% 23TCr
-0.89%-3.73%+35.46% - 5.07TCr
+2.60%-6.72%+129.64% - 906.33Cr
+0.20%+1.59%+4.55%-56.20% 676.62Cr
+5.85%+3.10%-8.61%+29.99% 476.03Cr
+2.12%+5.44%-32.83%-31.02% 450.32Cr
+1.30%-1.02%-12.21%-11.09% 379.22Cr
+1.25%-2.02%-30.48%-46.17% 329.04Cr
+0.63%+0.02%-23.08%-48.09% 256.57Cr
Average +1.45%-0.87%+6.90%-24.10% 3.52TCr
Weighted average by Cap. +0.29%-2.11%+7.99%-8.23%
Logo Laboratorios Andromaco S.A.
Laboratorios Andromaco SA is a Chile-based company primarily engaged, together with its subsidiaries, in the production, distribution and sale of a variety of pharmaceutical, cosmetic and diagnostic products, as well as clinic materials and veterinary drugs, among others. The Company's products portfolio comprises such brands as Abacten, Baxemin, Capent, Daivonex, Elcal, Flumed, Gabex, Histalen, Ibames, Kaion, Lactulosa, Micofin, Salbutamol, Clarimir, Dermaglos and Hipoglos, among others. Its facilities include two production plants intended for the production of hormonal and non-hormonal products, which are located in the Through its subsidiaries, the Company has operations established in Chile, Peru, Bolivia, Ecuador, Colombia, Panama, Costa Rica, El Salvador, the Dominican Republic, Guatemala and the British Virgin Islands. As of December 31, 2011, the Company's major shareholder was Inversiones NM Limitada with 35% of its interest.
Employees
-